Case of the Week
Section Editors: Matylda Machnowska1 and Anvita Pauranik2
1University of Toronto, Toronto, Ontario, Canada
2BC Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada
Sign up to receive an email alert when a new Case of the Week is posted.
February 22, 2024
POLR3B Homozygous Mutation (Hypomyelinating Leukodystrophy-8)
Background:
- POLR3-related leukodystrophies are a group of autosomal recessive hypomyelinating leukodystrophies caused by biallelic mutations in 1 of the 3 genes: POLR3A, POLR3B, and POLR1C. These genes basically encode for subunits of RNA polymerase III.
Clinical Presentation:
- Typically, patients present with 4 major clinical findings (which may be in varying degrees of presentation):
- neurologic dysfunction
- abnormal dentition
- hypogonadotrophic hypogonadism
- ocular abnormalities.
- The classic neurologic findings are slowly progressive intellectual disability and prominent cerebellar signs.
Key Diagnostic Features:
- Diffuse cerebral hypomyelination manifesting as diffuse T2/FLAIR hyperintensity
- Relative T2 hypointensity of basal ganglia, dentate nuclei, anterolateral thalami, and pyramidal tracts in the posterior limbs of internal capsules
- Cerebellar atrophy (notably vermian atrophy)
- Hypoplasia of corpus callosum
Differential Diagnoses:
- Hypomyelination with atrophy of basal ganglia and cerebellum (H-ABC): Early atrophy of basal ganglia is characteristic (especially putamen).
- Hypomyelination with congenital cataract (HCC): Clinical presence of cataracts; neuroimaging findings of marked periventricular T2 hyperintensity demonstrating corresponding T1-weighted hypointensity; cerebellar atrophy is rare.
- Pelizaeus Merzbacker disease: Homogeneous cerebral T2 hyperintense hypomyelination; early cerebellar atrophy is less common.
Treatment:
- Cell transplantation therapy, gene transfer therapy, and gene editing techniques are under research for the treatment of POLR3-related leukodystrophies.